Hamlet Abnousi
Vorstandsvorsitzender bei Abnousi Corporate Finance
Profil
Hamlet Abnousi is the founder of Scitech Global Ventures, Inc. founded in 2012.
He is currently the Chief Executive Officer at Abnousi Corporate Finance since 2007 and at Novobind Livestock Therapeutics, Inc. since 2012.
Mr. Abnousi's former position was as an Independent Director at Millennial Potash Corp.
He received his undergraduate degree from the University of British Columbia in 2000.
Aktive Positionen von Hamlet Abnousi
| Unternehmen | Position | Beginn |
|---|---|---|
| Abnousi Corporate Finance | Vorstandsvorsitzender | 01.12.2007 |
Novobind Livestock Therapeutics, Inc.
 Novobind Livestock Therapeutics, Inc. BiotechnologyHealth Technology Novobind Livestock Therapeutics, Inc. develops livestock therapeutics. Its molecules specifically target and neutralize multiple virulence factors necessary for the survival, infection, and proliferation of Salmonella in the GI. The company is headquartered in Vancouver, Canada. | Vorstandsvorsitzender | 01.10.2012 |
Ehemalige bekannte Positionen von Hamlet Abnousi
| Unternehmen | Position | Ende |
|---|---|---|
| Scitech Global Ventures, Inc. | Gründer | - |
| MILLENNIAL POTASH CORP. | Direktor/Vorstandsmitglied | - |
Ausbildung von Hamlet Abnousi
| University of British Columbia | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MILLENNIAL POTASH CORP. | Non-Energy Minerals |
| Private Unternehmen | 3 |
|---|---|
| Abnousi Corporate Finance | |
Novobind Livestock Therapeutics, Inc.
Novobind Livestock Therapeutics, Inc. BiotechnologyHealth Technology Novobind Livestock Therapeutics, Inc. develops livestock therapeutics. Its molecules specifically target and neutralize multiple virulence factors necessary for the survival, infection, and proliferation of Salmonella in the GI. The company is headquartered in Vancouver, Canada. | Health Technology |
| Scitech Global Ventures, Inc. |
